Maccura Biotechnology Co.Ltd engages in the research, development, manufacture, and sale of in vitro diagnostic products; and provides related services for medical laboratories in China and internationally. The company offers laboratory automation solutions, such as hematology analysis workstations; immunoassay products, such as chemiluminescence analyzers and reagents; molecular products, such as digital PCR and extraction systems, and PCR kits; urinalysis analyzer systems and semi-automatic urine analyzers; and hemostasis solutions, including coagulation and semi-automatic coagulation analyzers. It provides clinical chemistry products, such as glycohemoglobin and protein analyzer, biochemistry systems, and chemistry regents; blood group product solutions; and pathology solutions, such as a liquid-based cytology processing system. Maccura Biotechnology Co.Ltd was incorporated in 1994 and is headquartered in Chengdu, China.
Metrics to compare | 300463 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship300463PeersSector | |
---|---|---|---|---|
P/E Ratio | −191.1x | 54.6x | −0.5x | |
PEG Ratio | 1.70 | 0.30 | 0.00 | |
Price/Book | 1.2x | 3.6x | 2.6x | |
Price / LTM Sales | 3.3x | 6.9x | 3.3x | |
Upside (Analyst Target) | 5.7% | −3.0% | 42.9% | |
Fair Value Upside | Unlock | 8.6% | 6.2% | Unlock |